93966-67-7

Basic information

• Product Name: N-benzoyl-5'-O-[bis(p-methoxyphenyl)benzyl]-2'-deoxycytidine 3'-benzoate
• Synonyms: N-benzoyl-5'-O-[bis(p-methoxyphenyl)benzyl]-2'-deoxycytidine 3'-benzoate;N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxycytidine 3'-benzoate
• CAS NO: 93966-67-7
• Molecular Formula: C₄₄H₃₉N₃O₈
• Molecular Weight: 737.79576
• EINECS: 301-020-5
• Mol File: 93966-67-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-benzoyl-5'-O-[bis(p-methoxyphenyl)benzyl]-2'-deoxycytidine 3'-benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: N-benzoyl-5'-O-[bis(p-methoxyphenyl)benzyl]-2'-deoxycytidine 3'-benzoate(93966-67-7)
• EPA Substance Registry System: N-benzoyl-5'-O-[bis(p-methoxyphenyl)benzyl]-2'-deoxycytidine 3'-benzoate(93966-67-7)

Safety Data

• Hazardous Substances Data: 93966-67-7(Hazardous Substances Data)

Upstream product

• 98-07-7 Benzotrichlorid 
• 100-66-3 methoxybenzene 
• 40615-35-8 4,4'-dimethoxytrityl alcohol 
• 51549-49-6 N-benzoyl-2'-deoxycytidine 3'-benzoate 
• 98-88-4 benzoyl chloride 
• 67219-55-0 4-N-Benzoyl-2'-deoxy-5'-O-(4,4'-dimethoxytrityl)cytidine 

Downstream Products

• 51549-49-6 N-benzoyl-2'-deoxycytidine 3'-benzoate 

Relevant articles and documents

Renewable amberlyst-15 catalyzed highly regioselective tritylation and deprotection of sugar-based diols

Amberlyst-15 catalyzed highly regioselective tritylation of sugar-based diols was achieved under mild condition using 4,4′-dimethoxytrityl alcohol (DMTrOH). Deprotection of the corresponding DMTr group was also established by the variation to protic solvent. Meanwhile, the heterogeneous catalyst Amberlyst-15 was recycled 3 times with satisfactory retention of catalytic activity and proved its potential application in industry.

INHIBITORS OF RNA DEPENDENT RNA POLYMERASE AND USES THEREOF

The invention herein provides novel viral DNA polymerase compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with viral DNA polymerase activity, and processes and intermediates useful for preparing such compounds.